ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
FDA approval for Phelan-McDermid IND and Phase 2 trial
Published: 23/03/22, 09:44am (AEST)•2 pages